Protien kinase Cθ in T cell activation

Annual Review of Immunology

Volumn 20, Issue , 2002, Pages 761-794

  Isakov, Noah ^a   Altman, Amnon ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

IL 2; Immune synapse; NF B AP 1; PKC ; TCR CD28

Indexed keywords

BINDING PROTEIN; CBL PROTEIN; CD28 ANTIGEN; CYTOKINE; FAS LIGAND; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2; ISOENZYME; JANUS KINASE; NEF PROTEIN; PHOSPHATASE; PICOT PROTEIN; PROTEIN 14 3 3; PROTEIN KINASE B; PROTEIN KINASE C; PROTEIN KINASE FYN; PROTEIN KINASE LCK; PROTEIN SERINE THREONINE KINASE; RAC PROTEIN; RAS PROTEIN; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG; MITOGEN ACTIVATED PROTEIN KINASE; PRKCQ PROTEIN, HUMAN; STRESS ACTIVATED PROTEIN KINASE;

ANTIGEN PRESENTING CELL; APOPTOSIS; AUTOIMMUNE DISEASE; CELL ADHESION; CELLULAR DISTRIBUTION; CLONAL ANERGY; CYTOKINE PRODUCTION; EFFECTOR CELL; ENZYME ISOLATION; ENZYME STRUCTURE; GENE INDUCTION; IMMUNOSUPPRESSIVE TREATMENT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TISSUE DISTRIBUTION; TRANSPLANTATION; ANIMAL; BIOLOGICAL MODEL; CELL MEMBRANE; CYTOLOGY; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; T LYMPHOCYTE;

ANIMALS; APOPTOSIS; CLONAL ANERGY; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-2; ISOENZYMES; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LYMPHOCYTE ACTIVATION; MEMBRANE MICRODOMAINS; MITOGEN-ACTIVATED PROTEIN KINASES; MODELS, IMMUNOLOGICAL; NF-KAPPA B; PROTEIN KINASE C; RAS PROTEINS; T-LYMPHOCYTES; TRANSCRIPTION FACTOR AP-1;

EID: 85047682875     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.immunol.20.100301.064807     Document Type: Review

References (215)

1. The immunological synapse: A molecular machine controlling T cell activation
2. Three-dimensional segregation of supramolecular activation clusters in T cells
3. CD28/B7 system of T cell costimulation
4. CD28/B7 costimulation: A review
5. Molecular regulation of interleukin-2 expression by CD28 co-stimulation and anergy
6. Costimulatory regulation of T cell function
7. T lymphocyte costimulation mediated by reorganization of membrane microdomains
8. Tumor promoters in conjunction with calcium ionophores mimic antigenic stimulation by reactivation of alloantigen-primed murine T lymphocytes
9. Protein kinase C and calcium ion in mitogenic response of macrophage-depleted human peripheral lymphocytes
10. Early steps of lymphocyte activation bypassed by synergy between calcium ionophores and phorbol ester
11. Calcium ionophore plus phorbol ester can substitute for antigen in the induction of cytolytic T lymphocytes from specifically primed precursors
12. Protein kinase C and lipid signaling for sustained cellular responses
13. T lymphocyte activation: A biological model of signal transduction
14. Calcium-dependent protein kinase: Widespread occurrence in various tissues and phyla of the animal kingdom and comparison of effects of phospholipid, calmodulin, and trifluoperazine
15. A new possible regulatory system for protein phosphorylation in human peripheral lymphocytes. I. Characterization of a calcium-activated, phospholipid-dependent protein kinase
16. Phorbol diester receptor copurifies with protein kinase C
17. Protein kinase C as a possible receptor protein of tumor-promoting phorbol esters
18. Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters
19. Phorbol myristate acetate: A mitogen selective for a T-lymphocyte subpopulation
20. Lymphocyte activation by the tumor-promoting agent 12-O-tetradecanoyl-phorbol-13-acetate (TPA)
21. Valency of CD3 binding and internalization of the CD3 cell-surface complex control T cell responses to second signals: Distinction between effects on protein kinase C, cytoplasmic free calcium, and proliferation
22. Human T lymphocyte activation by tumor promoters: Role of protein kinase C
23. 2+, phospholipid-dependent protein kinase associated with plasma membrane
24. Association of protein kinase C activation with IL 2 receptor expression
25. Stimulation of T cells through the CD3/T-cell receptor complex: Role of cytoplasmic calcium, protein kinase C translocation, and phosphorylation of pp60c-src in the activation pathway
26. Reaction of T lymphocytes with anti-T3 induces translocation of C-kinase activity to the membrane and specific substrate phosphorylation
27. The role of protein kinase C in transmembrane signaling by the T cell antigen receptor complex. Effects of stimulation with soluble or immobilized CD3 antibodies
28. Molecular cloning and characterization of PKCθ, a novel member of the protein kinase C (PKC) gene family expressed predominantly in hematopoietic cells
29. A new member of the protein kinase C family, nPKCθ, predominantly expressed in skeletal muscle
30. Molecular cloning and expression of a cDNA encoding a novel isoenzyme of protein kinase C (nPKC). A new member of the nPKC family expressed in skeletal muscle, megakary-oblastic cells, and platelets
31. Mapping of the human protein kinase C-θ (PRKCQ) gene locus to the short arm of chromosome 10 (10p15) by FISH
32. Chromosomal abnormalities in adult T-cell leukemia/lymphoma (ATL)
33. DiGeorge anomaly associated with 10p deletion
34. Expression and biochemical characterization of human protein kinase C-θ
35. Protein kinase C: Structure, function, and regulation
36. Protein kinase C-θ isoenzyme selective stimulation of the transcription factor complex AP-1 in T lymphocytes
37. Direct interaction between protein kinase Cθ (PKCθ) and 14-3-3τ in T cells: 14-3-3 overexpression results in inhibition of PKCθ translocation and function
38. Expression of the major isoenzyme of protein kinase-C in skeletal muscle, nPKCθ, varies with muscle type and in response to fructose-induced insulin resistance
39. Unique expression pattern of protein kinase C-θ: High mRNA levels in normal mouse testes and in T-lymphocytic cells and neoplasms
40. Developmental regulation of a protein kinase C isoform localized in the neuromuscular junction
41. Protein kinase C isoenzymes in rat and human cardiovascular tissues
42. T cell expressed PKCθ demonstrates cell-type selective function
43. Protein kinase C-θ (PKCθ) distribution analysis in hematopoietic cells: Proliferating T cells exhibit high proportions of PKCθ in the particulate fraction
44. New perspectives on PKCθ, a member of the novel subfamily of protein kinase C
45. Fos and Jun: The AP-1 connection
46. AP-1 function and regulation
47. Signal transmission between the plasma membrane and nucleus of T lymphocytes
48. Transcriptional regulation of the IL-2 gene
49. PKC-θ is required for TCR-induced NF-κB activation in mature but not immature T lymphocytes
50. JNK is involved in signal integration during costimulation of T lymphocytes
51. Co-stimulation-dependent activation of a JNK-kinase in T lymphocytes
52. Calcineurin preferentially synergizes with PKC-θ to activate JNK and IL-2 promoter in T lymphocytes
53. Protein kinase Cθ, a selective upstream regulator of JNK/SAPK and IL-2 promoter activation in Jurkat T cells
54. JNK is required for effector T-cell function but not for T-cell activation
55. Regulation of c-Jun NH(2)-terminal kinase (Jnk) gene expression during T cell activation
56. The NF-κB and IκB proteins: New discoveries and insights
57. MAP3K-related kinase involved in NF-κB induction by TNF, CD95 and IL-1
58. NF-κB-inducing kinase activates IKK-α by phosphorylation of Ser-176
59. NF-κB activation by tumor necrosis factor requires the AKT serine-threonine kinase
60. MEKK1 activates both IκB kinase α and IκB β
61. Phosphorylation meets ubiquitination: The control of NF-κB activity
62. Identification and characterization of an IκB kinase
63. IκB kinase-β: NF-κB activation and complex formation with IκB kinase-a and NIK
64. The IκB kinase complex (IKK) contains two kinase subunits, IKKα and IKKβ, necessary for IκB phosphorylation and NF-κB activation
65. Control of IκB-α proteolysis by site-specific, signal-induced phosphorylation
66. Phosphorylation of human IκBα on serines 32 and 36 controls IκBα proteolysis and NF-κB activation in response to diverse stimuli
67. Signal-induced site-specific phosphorylation targets IκBα to the ubiquitin-proteasome pathway
68. Signal-induced degradation of IκBα requires site-specific ubiquitination
69. Signal transduction through NF-κB
70. Signal transduction by lymphocyte antigen receptors
71. The interleukin 2 CD28-responsive complex contains at least three members of the NF-κB family: c-Rel, p50, and p65
72. RelA is a potent transcriptional activator of the CD28 response element within the interleukin 2 promoter
73. Regulation of the interleukin-2 CD28-responsive element by NF-ATp and various NF-κB/Rel transcription factors
74. Involvement of Rel, Fos, and Jun proteins in binding activity to the IL-2 promoter CD28 response element/AP-1 sequence in human T cells
75. CD28 mediates transcriptional upregulation of the interleukin-2 (IL-2) promoter through a composite element containing the CD28RE and NF-IL-2B AP-1 sites
76. IκB kinases serve as a target of CD28 signaling
77. The proto-oncogene Cot kinase participates in CD3/CD28 induction of NF-κB acting through the NF-κB-inducing kinase and IκB kinases
78. The Jun kinase cascade is responsible for activating the CD28 response element of the IL-2 promoter: Proof of cross-talk with the IκB kinase cascade
79. NF-κB activation induced by T cell receptor/CD28 costimulation is mediated by protein kinase C-θ
80. Protein kinase C-θ participates in NF-κB activation induced by CD3-CD28 costimulation through selective activation of IκB kinase β
81. The physical association of protein kinase Cθ with a lipid raft-associated inhibitor of κB factor kinase (IKK) complex plays a role in the activation of the NF-κB cascade by TCR and CD28
82. Transcription factors of the NFAT family: Regulation and function
83. Activation of NFAT-dependent gene expression by Nef: Conservation among divergent Nef alleles, dependence on SH3 binding and membrane association, and cooperation with protein kinase C-θ
84. The -180 site of the IL-2 promoter is the target for CREB/CREM binding in T cell anergy
85. Protein kinase c-q participates in the activation of cyclic AMP-responsive element-binding protein and its subsequent binding to the -180 site of the IL-2 promoter in normal human T lymphocytes
86. Protein kinase Cθ: A new essential superstar on the T-cell stage
87. Different protein kinase C isoenzymes regulate IL-2 receptor expression or IL-2 synthesis in human lymphocytes stimulated via the TCR
88. Vav synergizes with protein kinase Cθ to mediate IL-4 gene expression in response to CD28 costimulation in T cells
89. Transactivation by AP-1 is a molecular target of T cell clonal anergy
90. + T cells
91. Defective transcription of the IL-2 gene is associated with impaired expression of c-Fos, FosB, and JunB in anergic T helper 1 cells
92. fyn
93. Induction of the increased Fyn kinase activity in anergic T helper type 1 clones requires calcium and protein synthesis and is sensitive to cyclosporin A
94. Differential association of protein tyrosine kinases with the T cell receptor is linked to the induction of anergy and its prevention by B7 family-mediated costimulation
95. Impaired plasma membrane targeting of Grb2-murine son of sevenless (mSOS) complex and differential activation of the Fyn-T cell receptor (TCR)-ζ-Cbl pathway mediate the T cell hyporesponsiveness in autoimmune nonobese diabetic mice
96. + T cells
97. The p38 mitogen-activated protein kinase pathway in activated and anergic Th1 cells
98. Maintenance of human T cell anergy: Blocking of IL-2 gene transcription by activated Rap1
99. + T cells express perturbed AP-1 and NF-κB transcription factors
100. Regulation of interleukin-2 gene enhancer activity by the T cell accessory molecule CD28
101. Increased c-Fos/activator protein-1 confers resistance against anergy induction on antigen-specific T cell
102. Overexpression of p65 and c-Jun substitutes for B7-1 costimulation by targeting the CD28RE within the IL-2 promoter
103. Lymphocyte responses and cytokines
104. A receptor/cytoskeletal movement triggered by costimulation during T cell activation
105. The actin cytoskeleton and lymphocyte activation
106. The immunological synapse and the actin cytoskeleton: Molecular hardware for T cell signaling
107. GPI-microdomains: A role in signalling via immunoreceptors
108. Membrane compartmentation and the response to antigen
109. The role of lipid rafts in T cell antigen receptor (TCR) signalling
110. Membrane lipid microdomains and the role of PKCθ in T cell activation
111. Signaling takes shape in the immune system
112. Selective modulation of protein kinase C-θ during T-cell activation
113. Functional rafts in cell membranes
114. Engagement of GPI-linked CD48 contributes to TCR signals and cytoskeletal reorganization: A role for lipid rafts in T cell activation
115. Antigen-induced translocation of PKC-θ to membrane rafts is required for T cell activation
116. Regulation of protein kinase Cθ function during T cell activation by Lck-mediated tyrosine phosphorylation
117. ZAP-70 and SLP-76 regulate protein kinase C-θ and NF-κB activation in response to engagement of CD3 and CD28
118. H2 cytokines
119. Complex formation and cooperation of PKC and Akt1/PKBa in the NF-κB transactivation cascade in Jurkat T cells
120. Costimulation: Building an immunological synapse
121. A novel functional interaction between Vav and PKCθ is required for TCR-induced T cell activation
122. Vav is a regulator of cytoskeletal reorganization mediated by the T-cell receptor
123. Defects in actin-cap formation in Vav-deficient mice implicate an actin requirement for lymphocyte signal transduction
124. Protein kinase C-θ phosphorylation of moesin in the actin-binding sequence
125. Moesin interacts with the cytoplasmic region of intercellular adhesion molecule-3 and is redistributed to the uropod of T lymphocytes during cell polarization
126. Membrane raft association of CD47 is necessary for actin polymerization and protein kinase Cθ translocation in its synergistic activation of T cells
127. Vav1/Rac-dependent actin cytoskeleton reorganization is required for lipid raft clustering in T cells
128. Role of substrates and products of PI 3-kinase in regulating activation of Rac-related guanosine triphosphatases by Vav
129. Structural basis for the relief of autoinhibition of the Dbl homology domain of proto-oncogene Vav by tyrosine phosphorylation
130. ras in T cells
131. RasGRP links T-cell receptor signaling to Ras
132. T cell antigen receptor signal transduction pathways
133. ras activation in T cell CD69 expression
134. New insights into the regulation of protein kinase C and novel phorbol ester receptors
135. Protein kinase C binding partners
136. 14-3-3 Proteins: Structure, function, and regulation
137. 14-3-3 Proteins and growth control
138. The Cbl family of signal transduction molecules
139. Cbl: Complex formation and functional implications
140. c-Cbl: A regulator of T cell receptor-mediated signalling
141. The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase
142. The Cbl protooncoprotein: A negative regulator of immune receptor signal transduction
143. Activation-modulated association of 14-3-3 proteins with Cbl in T cells
144. Serine phosphorylation of Cbl induced by phorbol ester enhances its association with 14-3-3 proteins in T cells via a novel serine-rich 14-3-3-binding motif
145. Protein kinase C activation inhibits tyrosine phosphorylation of Cbl and its recruitment of Src homology 2 domain-containing proteins
146. Regulation of lymphocyte function by protein phosphorylation
147. Myristylation and palmitylation of Src family members: The fats of the matter
148. Association of the fyn protein-tyrosine kinase with the T-cell antigen receptor
149. fyn protein tyrosine kinase in T cells
150. fyn)
151. fyn
152. fyn mutant mice display differential signaling in thymocytes and peripheral T cells
153. fyn tyrosine kinases and CD45 protein tyrosine phosphatase in T-cell development and clonal selection
154. lck
155. The lck tyrosine protein kinase interacts with the cytoplasmic tail of the CD4 glycoprotein through its unique amino-terminal domain
156. lck
157. Genetic evidence for the involvement of the lck tyrosine kinase in signal transduction through the T cell antigen receptor
158. A protein kinase C translocation inhibitor as an isozyme-selective antagonist of cardiac function
159. fyn
160. T-cell receptor antagonists induce Vav phosphorylation by selective activation of Fyn kinase
161. fyn in CD2-based signal transduction
162. Mechanisms and consequences of activation of protein kinase B/Akt
163. The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB
164. Induction of NF-κB by the Akt/PKB kinase
165. Protein kinase B regulates T lymphocyte survival, nuclear factor κB activation, and Bcl-X(L) levels in vivo
166. Inhibition of the c-Jun N-terminal kinase/AP-1 and NF-κB pathways by PICOT, a novel protein kinase C-interacting protein with a thioredoxin homology domain
167. PICOT-HD: A highly conserved protein domain that is often associated with thioredoxin and glutaredoxin modules
168. Unraveling the function of HIV type 1 Nef
169. Nef 27, but not the Nef 25 isoform of human immunodeficiency virus-type 1 pNL4.3 down-regulates surface CD4 and IL-2R expression in peripheral blood mononuclear cells and transformed T cells
170. Expression of the type 1 human immunodeficiency virus Nef protein in T cells prevents antigen receptor-mediated induction of interleukin 2 mRNA
171. Human immunodeficiency virus type 1 Nef protein down-regulates transcription factors NF-κB and AP-1 in human T cells in vitro after T-cell receptor stimulation
172. Human immunodeficiency virus type 1 Nef protein inhibits NF-κB induction in human T cells
173. HIV-1 Nef protein inhibits the recruitment of AP-1 DNA-binding activity in human T-cells
174. HIV-1 Nef increases T cell activation in a stimulus-dependent manner
175. The Nef protein of HIV-1 associates with rafts and primes T cells for activation
176. Nef harbors a major determinant of pathogenicity for an AIDS-like disease induced by HIV-1 in transgenic mice
177. Altered T cell activation and development in transgenic mice expressing the HIV-1 nef gene
178. Human immunodeficiency virus type 1 Nef associates with a cellular serine kinase in T lymphocytes
179. In vitro binding and phosphorylation of human immunodeficiency virus type 1 Nef protein by serine/threonine protein kinase
180. CDC42 and Rac1 are implicated in the activation of the Nef-associated kinase and replication of HIV-1
181. The association of Nef with a cellular serine/threonine kinase and its enhancement of infectivity are viral isolate dependent
182. The HIV Nef protein associates with protein kinase Cθ
183. Activation-induced death of mature T cells in the regulation of immune responses
184. Apoptosis by death factor
185. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)
186. Fas-ligand: Privilege and peril
187. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas
188. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation
189. Fas ligand-induced apoptosis
190. L
191. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt
192. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
193. L and Bcl-2, displaces Bax and promotes cell death
194. DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-κB and AP-1
195. Two NFAT transcription factor binding sites participate in the regulation of CD95 (Fas) ligand expression in activated human T cells
196. Transcriptional regulation of the human FasL promoter-enhancer region
197. Regulation of Fas-dependent activation-induced T cell apoptosis by cAMP signaling: A potential role for transcription factor NF-κB
198. Regulation of fas-ligand expression during activation-induced cell death in T lymphocytes via nuclear factor κB
199. A newly identified response element in the CD95 ligand promoter contributes to optimal inducibility in activated T lymphocytes
200. Regulation of CD95 (Fas) ligand expression by TCR-mediated signaling events
201. Apoptosis but not other activation events is inhibited by a mutation in the transmembrane domain of T cell receptor b that impairs CD3z association
202. Protein kinase cq cooperates with calcineurin to induce Fas ligand expression during activation-induced T cell death
203. Synergistic action of protein kinase Cθ and calcineurin is sufficient for Fas ligand expression and induction of a CrmA-sensitive apoptosis pathway in Jurkat T cells
204. Phorbol esters inhibit apoptosis in IL-2-dependent T lymphocytes
205. Phorbol ester inhibits DNA damage-induced apoptosis in U937 cells through activation of protein kinase C
206. + and cell shrinkage. A role for PKC upstream of caspases
207. Inhibition of the protein kinase C pathway promotes anti-CD95-induced apoptosis in Jurkat T cells
208. CD28 and apoptosis
209. Protein kinase Cθ and ε promote T-cell survival by a Rsk-dependent phosphorylation and inactivation of BAD
210. Protein kinase C-θ mediates a selective T cell survival signal via phosphorylation of BAD
211. RSK blocks Bad-mediated cell death via a protein kinase C-dependent pathway
212. Absolute dependence on κB responsive elements for initiation and Tat-mediated amplification of HIV transcription in blood CD4 T lymphocytes
213. Nuclear accumulation of NFAT4 opposed by the JNK signal transduction pathway
214. Identification of amino acid residues and protein kinases involved in the regulation of NFATc subcellular localization